IP Library Granted Patent US 11,484,706
Granted Patent B2
US 11,484,706 · App. 17/392,184 · Granted Nov 1, 2022

Disc therapy

Inventors: Yossi Gross (Moshav Mazor, IL); Gideon Fostick (Givat Shmuel, IL)
Assignee: Discure Technologies Ltd
A61N1/205A61N1/0551A61N1/306A61N1/325A61N1/326A61N1/327A61N1/3606
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,484,706
App. No.
17/392,184
Granted
Nov 1, 2022
Kind
B2
Abstract

Apparatus is provided for treating an intervertebral disc of a subject, the apparatus including: at least one intra-pulposus exposed electrode surface, which is configured to be implanted in a nucleus pulposus of the intervertebral disc; and one or more extra-pulposus exposed electrode surfaces, which are configured to be implanted outside the nucleus pulposus, in electrical communication with the intervertebral disc. Control circuitry is electrically coupled to the at least one intra-pulposus exposed electrode surface and one or more extra-pulposus exposed electrode surfaces. The control circuitry is configured to drive fluid and introduce nutritional substances into the intervertebral disc, by applying a voltage between the at least one intra-pulposus exposed electrode surface and the one or more extra-pulposus exposed electrode surfaces. Other embodiments are also described.

Claims (17)

1. Apparatus for treating an intervertebral disc of a subject, the apparatus comprising:

at least one intra-pulposus exposed electrode surface, which is configured to be implanted in a nucleus pulposus of the intervertebral disc;

one or more extra-pulposus exposed electrode surfaces, which are configured to be implanted outside the nucleus pulposus, in electrical communication with the intervertebral disc; and

control circuitry, which is (a) electrically coupled to the at least one intra-pulposus exposed electrode surface and one or more extra-pulposus exposed electrode surfaces, and (b) configured to drive fluid and introduce nutritional substances into the intervertebral disc, by applying a voltage between the at least one intra-pulposus exposed electrode surface and the one or more extra-pulposus exposed electrode surfaces.

2. The apparatus according to claim 1 , wherein the control circuitry is configured to configure the at least one intra-pulposus exposed electrode surface to be a cathode, and the one or more extra-pulposus exposed electrode surfaces to be one or more respective anodes.

3. The apparatus according to claim 1 , wherein the control circuitry is additionally configured to drive the at least one intra-pulposus exposed electrode surface and the one or more extra-pulposus exposed electrode surfaces to improve glucose metabolism in the intervertebral disc.

4. The apparatus according to claim 3 , wherein the control circuitry is configured to improve the glucose metabolism by driving the at least one intra-pulposus exposed electrode surface and the one or more extra-pulposus exposed electrode surfaces to generate oxygen within the nucleus pulposus by electrolysis.

5. The apparatus according to claim 3 , wherein the control circuitry is configured to configure the at least one intra-pulposus exposed electrode surface to be an anode, and the one or more extra-pulposus exposed electrode surfaces to be one or more respective cathodes.

6. The apparatus according to claim 1 , wherein the control circuitry is additionally configured to drive the at least one intra-pulposus exposed electrode surface and the one or more extra-pulposus exposed electrode surfaces to reduce lactic acid generation in the intervertebral disc.

7. The apparatus according to claim 6 , wherein the control circuitry is configured to reduce the lactic acid generation by driving the at least one intra-pulposus exposed electrode surface and the one or more extra-pulposus exposed electrode surfaces to generate oxygen within the nucleus pulposus by electrolysis.

8. The apparatus according to claim 6 , wherein the control circuitry is configured to configure the at least one intra-pulposus exposed electrode surface to be an anode, and the one or more extra-pulposus exposed electrode surfaces to be one or more respective cathodes.

9. Apparatus for treating an intervertebral disc of a subject, the apparatus comprising:

at least one intra-pulposus exposed electrode surface, which is configured to be implanted in a nucleus pulposus of the intervertebral disc;

one or more extra-pulposus exposed electrode surfaces, which are configured to be implanted outside the nucleus pulposus, in electrical communication with the intervertebral disc; and

control circuitry, which is (a) electrically coupled to the at least one intra-pulposus exposed electrode surface and one or more extra-pulposus exposed electrode surfaces, and (b) configured to improve glucose metabolism and reduce lactic acid generation in the intervertebral disc, by applying a voltage between the at least one intra-pulposus exposed electrode surface and the one or more extra-pulposus exposed electrode surfaces.

10. The apparatus according to claim 9 , wherein the control circuitry is configured to improve the glucose metabolism and reduce the lactic acid generation by driving the at least one intra-pulposus exposed electrode surface and the one or more extra-pulposus exposed electrode surfaces to generate oxygen within the nucleus pulposus by electrolysis.

11. The apparatus according to claim 9 , wherein the control circuitry is configured to configure the at least one intra-pulposus exposed electrode surface to be an anode, and the one or more extra-pulposus exposed electrode surfaces to be one or more respective cathodes.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 28, 2022
From: RAINBOW MEDICAL LTD.
To: DISCURE TECHNOLOGIES LTD.
Reel/Frame 059115/0357 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 22, 2021
From: GROSS, YOSSI; FOSTICK, GIDEON
To: RAINBOW MEDICAL LTD.
Reel/Frame 057891/0522 →
Continuity (7)
Continuation In Part 16695936 · Nov 26, 2019
Continuation 16064604
Continuation 14982187 · Dec 29, 2015
Continuation 17392184
Continuation 16332606
Continuation 15263910 · Sep 13, 2016
Related Publication 20210379369A1 · Dec 9, 2021